ATIDORTOXUMAB
UNII D5P066G5HL

Substance Identification & Data

This profile provides standardized clinical and technical data for Atidortoxumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D5P066G5HL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1939108-95-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
D5P066G5HL
CAS Registry Number
1939108-95-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ATIDORTOXUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C169792
National Cancer Institute reference terminology for clinical and research data.
INN ID
10638
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Atidortoxumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ATIDORTOXUMAB

Common Names & Synonyms

ASN-1
ATIDORTOXUMAB [INN]
IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS AUREUS .ALPHA.-HEMOLYSIN AND LEUKOCIDINS HLGAB, HLGCB, LUKED, AND LUKSF) (HUMAN MONOCLONAL ASN-1 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ASN-1 LIGHT-CHAIN, DIMER

Technical Codes

ASN-100 COMPONENT ASN-1

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus